Presentation is loading. Please wait.

Presentation is loading. Please wait.

Www.auritecpharma.com www.auritecpharma.com Sustained release tenofovir and maraviroc from an intravaginal ring in sheep World AIDS Conference July 2012.

Published byNelson Ramsey Modified over 9 years ago

Similar presentations

Presentation on theme: "Www.auritecpharma.com www.auritecpharma.com Sustained release tenofovir and maraviroc from an intravaginal ring in sheep World AIDS Conference July 2012."— Presentation transcript:

1 www.auritecpharma.com www.auritecpharma.com Sustained release tenofovir and maraviroc from an intravaginal ring in sheep World AIDS Conference July 2012 Presenter: TJ Smith

2 www.auritecpharma.com www.auritecpharma.com In vivo levels of TDF and MVC World AIDS Conference July 2012 Presenter: TJ Smith

3 www.auritecpharma.com www.auritecpharma.com Which drug(s)? Where? How much? Nobody knows. The ideal microbicide ring? Low-cost to manufacture Ability to deliver multiple drugs independently Ability to easily change drugs as new candidates become available Use of FDA approved ARTs World AIDS Conference July 2012 Presenter: TJ Smith

Download ppt "Www.auritecpharma.com www.auritecpharma.com Sustained release tenofovir and maraviroc from an intravaginal ring in sheep World AIDS Conference July 2012."

Similar presentations

Drug design and testing,. Drug Names Chemical name- describes its molecular structure and distinguishes it from other drugs.

Drug design and testing,. Drug Names Chemical name- describes its molecular structure and distinguishes it from other drugs.
Gilead’s Tech Transfer Partnerships and IP in India

Gilead’s Tech Transfer Partnerships and IP in India
What do we know? How do we move forward? Student Thinking Engagement Collaboration Questioning Visibility.

What do we know? How do we move forward? Student Thinking Engagement Collaboration Questioning Visibility.
Test practice Multiplication. Multiplication 9x2.

Test practice Multiplication. Multiplication 9x2.
Chapter Sixteen Science, Technology, and Global Health.

Chapter Sixteen Science, Technology, and Global Health.
Telling Time; Telling the Truth Engaging communities as stakeholders (and partners) in HIV vaccine R&D Mitchell Warren AVAC 2 July 2013 IAS Symposia Session:

Telling Time; Telling the Truth Engaging communities as stakeholders (and partners) in HIV vaccine R&D Mitchell Warren AVAC 2 July 2013 IAS Symposia Session:
HIV Treatment and Intellectual Property Rights: The Experience of the Medicines Patent Pool Esteban Burrone Melbourne – International AIDS Conference July.

HIV Treatment and Intellectual Property Rights: The Experience of the Medicines Patent Pool Esteban Burrone Melbourne – International AIDS Conference July.
 Biomedical HIV Prevention strategies Wim Vandevelde European AIDS Treatment Group (EATG) European Community Advisory Board (ECAB) Conference on HIV Infection.

 Biomedical HIV Prevention strategies Wim Vandevelde European AIDS Treatment Group (EATG) European Community Advisory Board (ECAB) Conference on HIV Infection.
News You Can Use… Lauren Gray, PharmD Candidate February 2015.

News You Can Use… Lauren Gray, PharmD Candidate February 2015.
Industry Trends and Tools for Generic Product Selection KATE KUHRT SHANGHAI JUNE 19-21, 2007.

Industry Trends and Tools for Generic Product Selection KATE KUHRT SHANGHAI JUNE 19-21, 2007.
Use of Antivirals in Prevention Oral and Topical Prophylaxis

Use of Antivirals in Prevention Oral and Topical Prophylaxis
The 4 th Decade of the HIV Epidemic: Midwest Regional Response September 17, 2013 with Jim Pickett, AFC/IRMA The Bottom Line on Rectal and Vaginal Microbicide.

The 4 th Decade of the HIV Epidemic: Midwest Regional Response September 17, 2013 with Jim Pickett, AFC/IRMA The Bottom Line on Rectal and Vaginal Microbicide.
Jim Pickett, IRMA/AFC GMHC – January 23, 2013 The Bottom Line on Rectal Microbicide Research.

Jim Pickett, IRMA/AFC GMHC – January 23, 2013 The Bottom Line on Rectal Microbicide Research.
Microbicide Research: A Promising HIV/AIDS Prevention Strategy for Women Roberta Black, Ph.D. Division of AIDS, National Institute of Allergy and Infectious.

Microbicide Research: A Promising HIV/AIDS Prevention Strategy for Women Roberta Black, Ph.D. Division of AIDS, National Institute of Allergy and Infectious.
1 Regulatory Concepts for Dual Indication Combination Products Charu Mullick, M.D. Division of Antiviral Products, CDER U.S. Food and Drug Administration.

1 Regulatory Concepts for Dual Indication Combination Products Charu Mullick, M.D. Division of Antiviral Products, CDER U.S. Food and Drug Administration.
Judy Manning, PhD Office of Population and Reproductive Health Bureau for Global Health From Ideal to Real: What’s in the MPT pipeline? “New Products,

Judy Manning, PhD Office of Population and Reproductive Health Bureau for Global Health From Ideal to Real: What’s in the MPT pipeline? “New Products,
Topical, Oral; Daily, Intermittent; Single, Combination agents; What do we need AND what will work? Patrick Ndase, Microbicide Trials Network & Dep’t of.

Topical, Oral; Daily, Intermittent; Single, Combination agents; What do we need AND what will work? Patrick Ndase, Microbicide Trials Network & Dep’t of.
Slide 1 of 9 From J Marrazzo, MD, at Los Angeles, CA: April 22, 2013, IAS-USA. IAS–USA Jeanne Marrazzo, MD, MPH Professor of Medicine University of Washington.

Slide 1 of 9 From J Marrazzo, MD, at Los Angeles, CA: April 22, 2013, IAS-USA. IAS–USA Jeanne Marrazzo, MD, MPH Professor of Medicine University of Washington.
Chapter 20: Conclusion and Future Directions The following visuals are scans of illustrations in the text. Each figure is labeled by the figure number.

Chapter 20: Conclusion and Future Directions The following visuals are scans of illustrations in the text. Each figure is labeled by the figure number.
XIX International AIDS Conference

XIX International AIDS Conference

Similar presentations

Ads by Google